A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin

Structure

Volumn 22, Issue 12, 2014, Pages 1711-1721

  Nagae, Masamichi ^a   Morita Matsumoto, Kana ^a   Kato, Masaki ^a   Kaneko, Mika Kato ^b   Kato, Yukinari ^b   Yamaguchi, Yoshiki ^a  

^a RIKEN   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; MEMBRANE PROTEIN; PROTEIN BINDING; RHODOCYTIN PROTEIN, CALLOSELASMA RHODOSTOMA; VIPER VENOM;

BINDING SITE; CHEMICAL STRUCTURE; GLYCOSYLATION; METABOLISM; THROMBOCYTE AGGREGATION; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; GLYCOSYLATION; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; PLATELET AGGREGATION; PROTEIN BINDING; VIPER VENOMS;

EID: 84914146149     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2014.09.009     Document Type: Article

References (48)

1. S.E. Acton, J.L. Astarita, D. Malhotra, V. Lukacs-Kornek, B. Franz, P.R. Hess, Z. Jakus, M. Kuligowski, A.L. Fletcher, and K.G. Elpek Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2 Immunity 37 2012 276 289
2. R.H. Adams, and K. Alitalo Molecular regulation of angiogenesis and lymphangiogenesis Nat. Rev. Mol. Cell Biol. 8 2007 464 478
3. K. Amano, Y. Chiba, Y. Kasahara, Y. Kato, M.K. Kaneko, A. Kuno, H. Ito, K. Kobayashi, J. Hirabayashi, Y. Jigami, and H. Narimatsu Engineering of mucin-type human glycoproteins in yeast cells Proc. Natl. Acad. Sci. USA 105 2008 3232 3237
4. C. Chaipan, E.J. Soilleux, P. Simpson, H. Hofmann, T. Gramberg, A. Marzi, M. Geier, E.A. Stewart, J. Eisemann, and A. Steinkasserer DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets J. Virol. 80 2006 8951 8960
5. C. Chaipan, I. Steffen, T.S. Tsegaye, S. Bertram, I. Glowacka, Y. Kato, J. Schmökel, J. Münch, G. Simmons, R. Gerardy-Schahn, and S. Pöhlmann Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2 Retrovirology 7 2010 47
6. C.M. Christou, A.C. Pearce, A.A. Watson, A.R. Mistry, A.Y. Pollitt, A.E. Fenton-May, L.A. Johnson, D.G. Jackson, S.P. Watson, and C.A. O'Callaghan Renal cells activate the platelet receptor CLEC-2 through podoplanin Biochem. J. 411 2008 133 140
7. Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography Acta Crystallogr. D Biol. Crystallogr. 50 1994 760 763
8. M. Colonna, J. Samaridis, and L. Angman Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells Eur. J. Immunol. 30 2000 697 704
9. K. Drickamer C-type lectin-like domains Curr. Opin. Struct. Biol. 9 1999 585 590
10. P. Emsley, and K. Cowtan Coot: model-building tools for molecular graphics Acta Crystallogr. D Biol. Crystallogr. 60 2004 2126 2132
11. J. Fu, H. Gerhardt, J.M. McDaniel, B. Xia, X. Liu, L. Ivanciu, A. Ny, K. Hermans, R. Silasi-Mansat, and S. McGee Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice J. Clin. Invest. 118 2008 3725 3737
12. Y. Fujii, M. Kaneko, M. Neyazaki, T. Nogi, Y. Kato, and J. Takagi PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin Protein Expr. Purif. 95 2014 240 247
13. B.H. Herzog, J. Fu, S.J. Wilson, P.R. Hess, A. Sen, J.M. McDaniel, Y. Pan, M. Sheng, T. Yago, and R. Silasi-Mansat Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2 Nature 502 2013 105 109
14. E. Hooley, E. Papagrigoriou, A. Navdaev, A.V. Pandey, J.M. Clemetson, K.J. Clemetson, and J. Emsley The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure Biochemistry 47 2008 7831 7837
15. K. Horii, D. Okuda, T. Morita, and H. Mizuno Crystal structure of EMS16 in complex with the integrin α2-I domain J. Mol. Biol. 341 2004 519 527
16. M.K. Kaneko, Y. Kato, T. Kitano, and M. Osawa Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor Gene 378 2006 52 57
17. M.K. Kaneko, Y. Kato, A. Kameyama, H. Ito, A. Kuno, J. Hirabayashi, T. Kubota, K. Amano, Y. Chiba, and Y. Hasegawa Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor FEBS Lett. 581 2007 331 336
18. M.K. Kaneko, A. Kunita, S. Abe, Y. Tsujimoto, M. Fukayama, K. Goto, Y. Sawa, Y. Nishioka, and Y. Kato Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity Cancer Sci. 103 2012 1913 1919
19. Y. Kato, and M.K. Kaneko A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin Sci. Rep. 4 2014 5924
20. Y. Kato, N. Fujita, A. Kunita, S. Sato, M. Kaneko, M. Osawa, and T. Tsuruo Molecular identification of Aggrus/T1α as a platelet aggregation-inducing factor expressed in colorectal tumors J. Biol. Chem. 278 2003 51599 51605
21. Y. Kato, M. Kaneko, M. Sata, N. Fujita, T. Tsuruo, and M. Osawa Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma Tumour Biol. 26 2005 195 200
22. Y. Kato, M.K. Kaneko, A. Kuno, N. Uchiyama, K. Amano, Y. Chiba, Y. Hasegawa, J. Hirabayashi, H. Narimatsu, K. Mishima, and M. Osawa Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain Biochem. Biophys. Res. Commun. 349 2006 1301 1307
23. Y. Kato, M.K. Kaneko, A. Kunita, H. Ito, A. Kameyama, S. Ogasawara, N. Matsuura, Y. Hasegawa, K. Suzuki-Inoue, and O. Inoue Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2 Cancer Sci. 99 2008 54 61
24. Y. Kato, G. Vaidyanathan, M.K. Kaneko, K. Mishima, N. Srivastava, V. Chandramohan, C. Pegram, S.T. Keir, C.T. Kuan, D.D. Bigner, and M.R. Zalutsky Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas Nucl. Med. Biol. 37 2010 785 794
25. A.M. Kerrigan, K.M. Dennehy, D. Mourão-Sá, I. Faro-Trindade, J.A. Willment, P.R. Taylor, J.A. Eble, C. Reis e Sousa, and G.D. Brown CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils J. Immunol. 182 2009 4150 4157
26. K. Kuroki, J. Wang, T. Ose, M. Yamaguchi, S. Tabata, N. Maita, S. Nakamura, M. Kajikawa, A. Kogure, and T. Satoh Structural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILRα Proc. Natl. Acad. Sci. USA 111 2014 8877 8882
27. S.C. Lovell, I.W. Davis, W.B. Arendall 3rd, P.I. de Bakker, J.M. Word, M.G. Prisant, J.S. Richardson, and D.C. Richardson Structure validation by Calpha geometry: φ,ψ and Cbeta deviation Proteins 50 2003 437 450
28. N. Maita, K. Nishio, E. Nishimoto, T. Matsui, Y. Shikamoto, T. Morita, J.E. Sadler, and H. Mizuno Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins J. Biol. Chem. 278 2003 37777 37781
29. H. Mizuno, Z. Fujimoto, H. Atoda, and T. Morita Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X Proc. Natl. Acad. Sci. USA 98 2001 7230 7234
30. G.N. Murshudov, A.A. Vagin, and E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr. D Biol. Crystallogr. 53 1997 240 255
31. M. Osada, O. Inoue, G. Ding, T. Shirai, H. Ichise, K. Hirayama, K. Takano, Y. Yatomi, M. Hirashima, and H. Fujii Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells J. Biol. Chem. 287 2012 22241 22252
32. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Macromolecular Crystallography Pt. A 276 1997 307 326
33. S. Radaev, and P.D. Sun Structure and function of natural killer cell surface receptors Annu. Rev. Biophys. Biomol. Struct. 32 2003 93 114
34. V. Schacht, M.I. Ramirez, Y.K. Hong, S. Hirakawa, D. Feng, N. Harvey, M. Williams, A.M. Dvorak, H.F. Dvorak, G. Oliver, and M. Detmar T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema EMBO J. 22 2003 3546 3556
35. Y. Shin, and T. Morita Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib Biochem. Biophys. Res. Commun. 245 1998 741 745
36. W.S. Somers, J. Tang, G.D. Shaw, and R.T. Camphausen Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLeX and PSGL-1 Cell 103 2000 467 479
37. K. Suzuki-Inoue, G.L. Fuller, A. García, J.A. Eble, S. Pöhlmann, O. Inoue, T.K. Gartner, S.C. Hughan, A.C. Pearce, and G.D. Laing A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2 Blood 107 2006 542 549
38. K. Suzuki-Inoue, Y. Kato, O. Inoue, M.K. Kaneko, K. Mishima, Y. Yatomi, Y. Yamazaki, H. Narimatsu, and Y. Ozaki Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells J. Biol. Chem. 282 2007 25993 26001
39. T. Tammela, and K. Alitalo Lymphangiogenesis: Molecular mechanisms and future promise Cell 140 2010 460 476
40. A. Vagin, and A. Teplyakov Molecular replacement with MOLREP Acta Crystallogr. D Biol. Crystallogr. 66 2010 22 25
41. J. Wang, I. Shiratori, T. Satoh, L.L. Lanier, and H. Arase An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR) J. Immunol. 180 2008 1686 1693
42. J. Wang, Q. Fan, T. Satoh, J. Arii, L.L. Lanier, P.G. Spear, Y. Kawaguchi, and H. Arase Binding of herpes simplex virus glycoprotein B (gB) to paired immunoglobulin-like type 2 receptor α depends on specific sialylated O-linked glycans on gB J. Virol. 83 2009 13042 13045
43. A.A. Watson, and C.A. O'Callaghan Crystallization and X-ray diffraction analysis of human CLEC-2 Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61 2005 1094 1096
44. A.A. Watson, J. Brown, K. Harlos, J.A. Eble, T.S. Walter, and C.A. O'Callaghan The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2 J. Biol. Chem. 282 2007 3165 3172
45. A.A. Watson, J.A. Eble, and C.A. O'Callaghan Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2 Protein Sci. 17 2008 1611 1616
46. A.A. Watson, C.M. Christou, J.R. James, A.E. Fenton-May, G.E. Moncayo, A.R. Mistry, S.J. Davis, R.J. Gilbert, A. Chakera, and C.A. O'Callaghan The platelet receptor CLEC-2 is active as a dimer Biochemistry 48 2009 10988 10996
47. W.M. Yokoyama, and B.F. Plougastel Immune functions encoded by the natural killer gene complex Nat. Rev. Immunol. 3 2003 304 316
48. A.N. Zelensky, and J.E. Gready The C-type lectin-like domain superfamily FEBS J. 272 2005 6179 6217